Backed by Hen­ri Ter­meer es­tate, Au­ra rais­es $30M for work to pre­vent blind­ness in eye can­cer pa­tients

Cam­bridge, MA biotech Au­ra Bio­sciences has raised $30 mil­lion in a Se­ries C round to take its light-ac­ti­vat­ed nanopar­ti­cle tech in­to late-stage tri­als for eye …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER